Hospital-acquired bacterial pneumonia (HABP)
Clinical trials for Hospital-acquired bacterial pneumonia (HABP) explained in plain language.
Never miss a new study
Get alerted when new Hospital-acquired bacterial pneumonia (HABP) trials appear
Sign up with your email to follow new studies for Hospital-acquired bacterial pneumonia (HABP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new antibiotic outmatch an old one against Drug-Resistant pneumonia?
Disease control Recruiting nowThis trial is testing an experimental antibiotic called ASK0912 against an older drug, polymyxin B, in adults with hospital-acquired or ventilator-associated pneumonia caused by multidrug-resistant bacteria. Participants will receive one of two dosing schedules of ASK0912 or the …
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA (HABP)
Phase 2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New antibiotic cocktail takes on superbug pneumonia in hospitals
Disease control Recruiting nowThis phase 3 trial tests a new antibiotic combination (BV100 plus low-dose polymyxin B) against a standard treatment (colistin plus ampicillin/sulbactam) for hospital-acquired or ventilator-associated pneumonia caused by a drug-resistant bacteria called CRABC. The study will enro…
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA (HABP)
Phase 3 • Sponsor: BioVersys SAS • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC